Vertex Pharmaceuticals Inc (VRTX) 64.17 $VRTX
The S&P 500's 3 Biggest Biotech Losers of 2014
Keith Speights, The Motley Fool - Motley Fool - Wed Apr 16, 1:30PM CDT
What goes up must come down. The law of gravity applies to physics -- and the stock market. This has been readily apparent in 2014 with biotech stocks. After taking the world by storm over the previous two years, many stocks in the sector instead...
Analysts View on Biotech Equities -- Research on Organovo Holdings, BioMarin Pharma, Vertex Pharma, and Spectrum Pharma
PR Newswire - Tue Apr 15, 10:15AM CDT
On Monday, April 14, 2014, the NASDAQ Composite ended at 4,022.69, up 0.57%, the Dow Jones Industrial Average advanced 0.91%, to finish the day at 16,173.24, and the S&P 500 closed at 1,830.61, up 0.82%. The gains were broad based as all the sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 648.05, up 0.51%, while the same has fallen by 1.86% in the previous three months. Investor-Edge has initiated coverage on the following equities: Organovo Holdings Inc. (NYSE MKT: ONVO), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) and Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI). Free technical research on ONVO, BMRN, VRTX and SPPI can be downloaded upon signing up at:
Vertex Pharmaceuticals Has Returned 12.0% Since SmarTrend Recommendation (VRTX)
Comtex SmarTrend(R) - Mon Apr 14, 9:23AM CDT
SmarTrend identified a Downtrend for Vertex Pharmaceuticals (NASDAQ:VRTX) on March 24th, 2014 at $72.59. In approximately 3 weeks, Vertex Pharmaceuticals has returned 11.97% as of today's recent price of $63.90.
Stock Market News for April 14, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Mon Apr 14, 9:06AM CDT
Another day of selling pressure in bio-tech and technology stocks dragged the benchmarks down on Friday
'Fast Money' Recap: The Skid Continues
at The Street - Sat Apr 12, 4:00AM CDT
The trading panel looked at General Motors and wondered how low it can go.
Why Biogen Idec Inc., Vertex Pharmaceuticals Incorporated, and Broadcom Corp. Are Today’s 3 Worst St
John Divine, The Motley Fool - Motley Fool - Fri Apr 11, 6:51PM CDT
The sell-off in high-growth companies -- especially in tech and biotech names -- continued to snowball on Friday. What began last month with a single letter from three congressmen questioning the pricing of Gilead Sciences ' Sovaldi has turned into...
Vertex to Announce First Quarter 2014 Financial Results on May 1
Business Wire - Thu Apr 10, 3:05PM CDT
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its first quarter 2014 financial results on Thursday, May 1, 2014 after the financial markets close. The company will host a conference call and webcast at 5:00 p.m. ET. To access the call, please dial (866) 501-1537 (U.S.) or +1 (720) 545-0001 (International).
Nasdaq Up 1.7%; Bed, Bath & Beyond Sinks After Hours
at Investor's Business Daily - Wed Apr 09, 4:13PM CDT
The major averages climbed more than 1% Wednesday, as more earnings reports came out after the closing bell. The Nasdaq led the way, climbing 1.7%. The Dow Jones industrial average and S&P 500 each rose 1.1%. But NYSE and Nasdaq volume was...
Momentum Slide to Continue for Netflix, Facebook? - Analyst Blog
Swarup Gupta - Zacks Investment Research - Mon Apr 07, 12:21PM CDT
Momentum stocks may soon bounce back, but for now earnings hold the key.
Vertex Pharmaceuticals Falls 4.40% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Thu Apr 03, 4:44PM CDT
Vertex Pharmaceuticals (NASDAQ:VRTX) traded in a range yesterday that spanned from a low of $67.93 to a high of $72.74. Yesterday, the shares fell 4.4%, which took the trading range below the 3-day low of $68.01 on volume of 1.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Look for Shares of Vertex Pharmaceuticals to Potentially Rebound after Yesterday's 4.40% Sell Off
Comtex SmarTrend(R) - Thu Apr 03, 4:43PM CDT
Vertex Pharmaceuticals (NASDAQ:VRTX) traded in a range yesterday that spanned from a low of $67.93 to a high of $72.74. Yesterday, the shares fell 4.4%, which took the trading range below the 3-day low of $68.01 on volume of 1.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Dow Little Changed as Service Sector Job Growth Hits Lowest Level in a Year
at The Street - Thu Apr 03, 3:20PM CDT
U.S. stocks close little changed Thursday as jobs growth in the service sector hits its lowest level in a year and unemployment claims rise.
Tradable Biotech Stocks Events For the Second Quarter
at The Street - Thu Apr 03, 8:00AM CDT
The biotech sector's March "fluctuation" might be a temporary speed bump or the beginning of a longer downturn. Either way, investors can still count on the biotech catalyst trade for chills and thrills.
IdeaPaint Forms Direct Selling Team to Service Architects, Interior Designers and Commercial Office Building Contractors.
Business Wire - Tue Apr 01, 8:01AM CDT
The growing nationwide demand for more modern, attractive workplaces has created an uptick in sales of IdeaPaint's high-performance dry erase paint that turns any smooth surfaces into an erasable canvas to facilitate greater collaboration and innovation among employees. To better fulfill this demand primarily from architects, interior designers, building and painting contractors, IdeaPaint today announced that it has formed a direct sales team to sell its award-winning products directly to this community, thus replacing previous independent representation with a dedicated world-class sales force. This move will deliver faster, more personalized service, breakthrough design innovation thought leadership, high-touch consulting and new growth opportunities to the burgeoning office building and design community.
Stock Market News for March 31, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Mon Mar 31, 9:06AM CDT
Markets snapped two days of losses and ended higher on Friday boosted by encouraging consumer spending data
Why Biogen Idec, Vertex Pharmaceuticals, and PG&E Are Today’s 3 Worst Stocks
John Divine, The Motley Fool - Motley Fool - Fri Mar 28, 7:03PM CDT
Eight in 10 sectors advanced in the stock market today, as the S&P 500 Index added eight points, or 0.5%, to end at 1,857. The health-care sector again stood out as an underperformer, continuing a week-long trend that began last Friday. While...
The S&P 500's 3 Biggest Biotech Losers of 2014
Keith Speights, The Motley Fool - Motley Fool - Wed Apr 16, 1:30PM CDT
What goes up must come down. The law of gravity applies to physics -- and the stock market. This has been readily apparent in 2014 with biotech stocks. After taking the world by storm over the previous two years, many stocks in the sector instead...
Analysts View on Biotech Equities -- Research on Organovo Holdings, BioMarin Pharma, Vertex Pharma, and Spectrum Pharma
PR Newswire - Tue Apr 15, 10:15AM CDT
On Monday, April 14, 2014, the NASDAQ Composite ended at 4,022.69, up 0.57%, the Dow Jones Industrial Average advanced 0.91%, to finish the day at 16,173.24, and the S&P 500 closed at 1,830.61, up 0.82%. The gains were broad based as all the sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 648.05, up 0.51%, while the same has fallen by 1.86% in the previous three months. Investor-Edge has initiated coverage on the following equities: Organovo Holdings Inc. (NYSE MKT: ONVO), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) and Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI). Free technical research on ONVO, BMRN, VRTX and SPPI can be downloaded upon signing up at:
Vertex Pharmaceuticals Has Returned 12.0% Since SmarTrend Recommendation (VRTX)
Comtex SmarTrend(R) - Mon Apr 14, 9:23AM CDT
SmarTrend identified a Downtrend for Vertex Pharmaceuticals (NASDAQ:VRTX) on March 24th, 2014 at $72.59. In approximately 3 weeks, Vertex Pharmaceuticals has returned 11.97% as of today's recent price of $63.90.
Stock Market News for April 14, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Mon Apr 14, 9:06AM CDT
Another day of selling pressure in bio-tech and technology stocks dragged the benchmarks down on Friday
'Fast Money' Recap: The Skid Continues
at The Street - Sat Apr 12, 4:00AM CDT
The trading panel looked at General Motors and wondered how low it can go.
Why Biogen Idec Inc., Vertex Pharmaceuticals Incorporated, and Broadcom Corp. Are Today’s 3 Worst St
John Divine, The Motley Fool - Motley Fool - Fri Apr 11, 6:51PM CDT
The sell-off in high-growth companies -- especially in tech and biotech names -- continued to snowball on Friday. What began last month with a single letter from three congressmen questioning the pricing of Gilead Sciences ' Sovaldi has turned into...
Vertex to Announce First Quarter 2014 Financial Results on May 1
Business Wire - Thu Apr 10, 3:05PM CDT
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its first quarter 2014 financial results on Thursday, May 1, 2014 after the financial markets close. The company will host a conference call and webcast at 5:00 p.m. ET. To access the call, please dial (866) 501-1537 (U.S.) or +1 (720) 545-0001 (International).
Nasdaq Up 1.7%; Bed, Bath & Beyond Sinks After Hours
at Investor's Business Daily - Wed Apr 09, 4:13PM CDT
The major averages climbed more than 1% Wednesday, as more earnings reports came out after the closing bell. The Nasdaq led the way, climbing 1.7%. The Dow Jones industrial average and S&P 500 each rose 1.1%. But NYSE and Nasdaq volume was...
Momentum Slide to Continue for Netflix, Facebook? - Analyst Blog
Swarup Gupta - Zacks Investment Research - Mon Apr 07, 12:21PM CDT
Momentum stocks may soon bounce back, but for now earnings hold the key.
Vertex Pharmaceuticals Falls 4.40% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Thu Apr 03, 4:44PM CDT
Vertex Pharmaceuticals (NASDAQ:VRTX) traded in a range yesterday that spanned from a low of $67.93 to a high of $72.74. Yesterday, the shares fell 4.4%, which took the trading range below the 3-day low of $68.01 on volume of 1.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Look for Shares of Vertex Pharmaceuticals to Potentially Rebound after Yesterday's 4.40% Sell Off
Comtex SmarTrend(R) - Thu Apr 03, 4:43PM CDT
Vertex Pharmaceuticals (NASDAQ:VRTX) traded in a range yesterday that spanned from a low of $67.93 to a high of $72.74. Yesterday, the shares fell 4.4%, which took the trading range below the 3-day low of $68.01 on volume of 1.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Dow Little Changed as Service Sector Job Growth Hits Lowest Level in a Year
at The Street - Thu Apr 03, 3:20PM CDT
U.S. stocks close little changed Thursday as jobs growth in the service sector hits its lowest level in a year and unemployment claims rise.
Tradable Biotech Stocks Events For the Second Quarter
at The Street - Thu Apr 03, 8:00AM CDT
The biotech sector's March "fluctuation" might be a temporary speed bump or the beginning of a longer downturn. Either way, investors can still count on the biotech catalyst trade for chills and thrills.
IdeaPaint Forms Direct Selling Team to Service Architects, Interior Designers and Commercial Office Building Contractors.
Business Wire - Tue Apr 01, 8:01AM CDT
The growing nationwide demand for more modern, attractive workplaces has created an uptick in sales of IdeaPaint's high-performance dry erase paint that turns any smooth surfaces into an erasable canvas to facilitate greater collaboration and innovation among employees. To better fulfill this demand primarily from architects, interior designers, building and painting contractors, IdeaPaint today announced that it has formed a direct sales team to sell its award-winning products directly to this community, thus replacing previous independent representation with a dedicated world-class sales force. This move will deliver faster, more personalized service, breakthrough design innovation thought leadership, high-touch consulting and new growth opportunities to the burgeoning office building and design community.
Stock Market News for March 31, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Mon Mar 31, 9:06AM CDT
Markets snapped two days of losses and ended higher on Friday boosted by encouraging consumer spending data
Why Biogen Idec, Vertex Pharmaceuticals, and PG&E Are Today’s 3 Worst Stocks
John Divine, The Motley Fool - Motley Fool - Fri Mar 28, 7:03PM CDT
Eight in 10 sectors advanced in the stock market today, as the S&P 500 Index added eight points, or 0.5%, to end at 1,857. The health-care sector again stood out as an underperformer, continuing a week-long trend that began last Friday. While...
